SEPTInvestingStart Free

BBNX SCHEDULE 13G/A: SEC filing

Farallon Capital Management and affiliated individuals

Filed with the SEC on · accession 0000908834-26-000395

BBNX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +4.3% by the first close after the filing.

Summary of the filing

Farallon Capital Management and affiliated individuals filed a joint acquisition statement (Amendment to Schedule 13G) regarding their passive ownership position in Beta Bionics, Inc. The filing is a procedural joint filing agreement with no change in ownership disclosed in the excerpt.

For details, click here →

Key details

Reporting person / filerFarallon Capital Management, L.L.C.
Issuer of securities heldBeta Bionics, Inc.
Managing member, farallon capital management, l.l.c.Hannah E. Dunn
Reporting person (attorney-in-fact)Joshua J. Dapice
Reporting person (attorney-in-fact)Philip D. Dreyfuss
Reporting person (attorney-in-fact)Varun N. Gehani
Reporting person (attorney-in-fact)Nicolas Giauque
Reporting person (attorney-in-fact)Avner A. Husen
Reporting person (attorney-in-fact)David T. Kim
Reporting person (attorney-in-fact)Michael G. Linn
Reporting person (attorney-in-fact)Patrick (Cheng) Luo
Reporting person (attorney-in-fact)Thomas G. Roberts, Jr.
Reporting person (attorney-in-fact)Edric C. Saito
Reporting person (attorney-in-fact)Daniel S. Short
Reporting person (attorney-in-fact)Andrew J. M. Spokes
Reporting person (attorney-in-fact)John R. Warren
Reporting person (attorney-in-fact)Mark C. Wehrly

How BBNX stock reacted

Close before

$17.33

Aug 12, 2026

First close after

+4.33%

$18.08

5 trading days

+15.46%

$20.01

Since filing

-9.41%

$15.70

✦ Ask GOAX AI about this filing — what it means for BBNX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BBNX?

Click here

Frequently asked questions

What did BBNX file with the SEC on Aug 13, 2026?

BBNX filed a SCHEDULE 13G/A (SEC filing). Farallon Capital Management and affiliated individuals filed a joint acquisition statement (Amendment to Schedule 13G) regarding their passive ownership position in Beta Bionics, Inc. The filing is a procedural joint filing agreement with no change in ownership disclosed in the excerpt.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did BBNX stock react to this filing?

BBNX closed at $17.33 before the filing and $18.08 on Aug 13, 2026 (+4.33%). Five trading days later: $20.01 (+15.46%).

Other BBNX SEC filings

Get alerts when BBNX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
BBNX overviewBBNX analysisBBNX newsLatest SEC filings